Discovery, Optimization, and Evaluation of Novel N-(Benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine Analogues as Potent STAT3 Inhibitors for Cancer Treatment Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1021/acs.jmedchem.3c00863
Signal transducer and activator of transcription 3 (STAT3) is an attractive target for cancer therapy. However, identifying potent and selective STAT3 small-molecule inhibitors with drug-like properties remains challenging. Based on a scaffold combination strategy, compounds with a novel N-(benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine scaffold were designed and their inhibition of the interleukin-6 (IL-6)/JAK/STAT3 pathway was tested in HEK-Blue IL-6 reporter cells. After optimization of lead compound 12, compound 40 was identified as a selective STAT3 inhibitor that directly binds the SH2 domain to inhibit STAT3 phosphorylation, translocation, and downstream gene transcription. Compound 40 exhibited antiproliferative activities against STAT3-overactivated DU145 (IC50 value = 2.97 μM) and MDA-MB-231 (IC50 value = 3.26 μM) cancer cells and induced cell cycle arrest and apoptosis. In the DU145 xenograft model, compound 40 showed in vivo antitumor efficacy following intraperitoneal administration, with a tumor growth inhibition rate of 65.3% at 50 mg/kg, indicating promise for further development.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1021/acs.jmedchem.3c00863
- OA Status
- green
- Cited By
- 13
- References
- 40
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4385968395
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4385968395Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1021/acs.jmedchem.3c00863Digital Object Identifier
- Title
-
Discovery, Optimization, and Evaluation of Novel N-(Benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine Analogues as Potent STAT3 Inhibitors for Cancer TreatmentWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-08-18Full publication date if available
- Authors
-
Ru Wang, Tingting Du, Wenqiang Liu, Yichen Liu, Y. H. Yang, Jinping Hu, Ming Ji, Beibei Yang, Li Li, Xiaoguang ChenList of authors in order
- Landing page
-
https://doi.org/10.1021/acs.jmedchem.3c00863Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.7270/q23b64g6Direct OA link when available
- Concepts
-
Chemistry, DU145, STAT3, In vivo, IC50, STAT protein, Pharmacology, Apoptosis, Cancer cell, Lead compound, Biochemistry, Cancer, In vitro, Biology, Biotechnology, LNCaP, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
13Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 6, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
40Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4385968395 |
|---|---|
| doi | https://doi.org/10.1021/acs.jmedchem.3c00863 |
| ids.doi | https://doi.org/10.1021/acs.jmedchem.3c00863 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37594012 |
| ids.openalex | https://openalex.org/W4385968395 |
| fwci | 3.08876135 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D050796 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | STAT3 Transcription Factor |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000588 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Amines |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D015850 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Interleukin-6 |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D018909 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | src Homology Domains |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D017209 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Apoptosis |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D009369 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Neoplasms |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D050796 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | STAT3 Transcription Factor |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000588 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Amines |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D015850 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Interleukin-6 |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D018909 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | src Homology Domains |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D017209 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Apoptosis |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D009369 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Neoplasms |
| type | article |
| title | Discovery, Optimization, and Evaluation of Novel N-(Benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine Analogues as Potent STAT3 Inhibitors for Cancer Treatment |
| biblio.issue | 17 |
| biblio.volume | 66 |
| biblio.last_page | 12395 |
| biblio.first_page | 12373 |
| grants[0].funder | https://openalex.org/F4320323137 |
| grants[0].award_id | 2016-I2M-3-009 |
| grants[0].funder_display_name | Chinese Academy of Medical Sciences |
| grants[1].funder | https://openalex.org/F4320323137 |
| grants[1].award_id | 2021-1-I2M-026 |
| grants[1].funder_display_name | Chinese Academy of Medical Sciences |
| topics[0].id | https://openalex.org/T11503 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cytokine Signaling Pathways and Interactions |
| topics[1].id | https://openalex.org/T12318 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.9977999925613403 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1605 |
| topics[1].subfield.display_name | Organic Chemistry |
| topics[1].display_name | Quinazolinone synthesis and applications |
| topics[2].id | https://openalex.org/T10274 |
| topics[2].field.id | https://openalex.org/fields/16 |
| topics[2].field.display_name | Chemistry |
| topics[2].score | 0.9973999857902527 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1605 |
| topics[2].subfield.display_name | Organic Chemistry |
| topics[2].display_name | Synthesis and biological activity |
| funders[0].id | https://openalex.org/F4320323137 |
| funders[0].ror | https://ror.org/03cve4549 |
| funders[0].display_name | Chinese Academy of Medical Sciences |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C185592680 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8084284067153931 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[0].display_name | Chemistry |
| concepts[1].id | https://openalex.org/C2776438761 |
| concepts[1].level | 5 |
| concepts[1].score | 0.7509605288505554 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5206280 |
| concepts[1].display_name | DU145 |
| concepts[2].id | https://openalex.org/C2778923194 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7018250226974487 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q14912019 |
| concepts[2].display_name | STAT3 |
| concepts[3].id | https://openalex.org/C207001950 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6064722537994385 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q141124 |
| concepts[3].display_name | In vivo |
| concepts[4].id | https://openalex.org/C2777752497 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5497838854789734 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q286779 |
| concepts[4].display_name | IC50 |
| concepts[5].id | https://openalex.org/C171958077 |
| concepts[5].level | 4 |
| concepts[5].score | 0.543725311756134 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q419333 |
| concepts[5].display_name | STAT protein |
| concepts[6].id | https://openalex.org/C98274493 |
| concepts[6].level | 1 |
| concepts[6].score | 0.47940561175346375 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[6].display_name | Pharmacology |
| concepts[7].id | https://openalex.org/C190283241 |
| concepts[7].level | 2 |
| concepts[7].score | 0.442425012588501 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q14599311 |
| concepts[7].display_name | Apoptosis |
| concepts[8].id | https://openalex.org/C96232424 |
| concepts[8].level | 3 |
| concepts[8].score | 0.43403393030166626 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q4118072 |
| concepts[8].display_name | Cancer cell |
| concepts[9].id | https://openalex.org/C2777752112 |
| concepts[9].level | 3 |
| concepts[9].score | 0.42888760566711426 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q903238 |
| concepts[9].display_name | Lead compound |
| concepts[10].id | https://openalex.org/C55493867 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3126062750816345 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[10].display_name | Biochemistry |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.2614113986492157 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C202751555 |
| concepts[12].level | 2 |
| concepts[12].score | 0.2440468966960907 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[12].display_name | In vitro |
| concepts[13].id | https://openalex.org/C86803240 |
| concepts[13].level | 0 |
| concepts[13].score | 0.10966086387634277 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[13].display_name | Biology |
| concepts[14].id | https://openalex.org/C150903083 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7108 |
| concepts[14].display_name | Biotechnology |
| concepts[15].id | https://openalex.org/C2779723316 |
| concepts[15].level | 4 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q6459234 |
| concepts[15].display_name | LNCaP |
| concepts[16].id | https://openalex.org/C54355233 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[16].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/chemistry |
| keywords[0].score | 0.8084284067153931 |
| keywords[0].display_name | Chemistry |
| keywords[1].id | https://openalex.org/keywords/du145 |
| keywords[1].score | 0.7509605288505554 |
| keywords[1].display_name | DU145 |
| keywords[2].id | https://openalex.org/keywords/stat3 |
| keywords[2].score | 0.7018250226974487 |
| keywords[2].display_name | STAT3 |
| keywords[3].id | https://openalex.org/keywords/in-vivo |
| keywords[3].score | 0.6064722537994385 |
| keywords[3].display_name | In vivo |
| keywords[4].id | https://openalex.org/keywords/ic50 |
| keywords[4].score | 0.5497838854789734 |
| keywords[4].display_name | IC50 |
| keywords[5].id | https://openalex.org/keywords/stat-protein |
| keywords[5].score | 0.543725311756134 |
| keywords[5].display_name | STAT protein |
| keywords[6].id | https://openalex.org/keywords/pharmacology |
| keywords[6].score | 0.47940561175346375 |
| keywords[6].display_name | Pharmacology |
| keywords[7].id | https://openalex.org/keywords/apoptosis |
| keywords[7].score | 0.442425012588501 |
| keywords[7].display_name | Apoptosis |
| keywords[8].id | https://openalex.org/keywords/cancer-cell |
| keywords[8].score | 0.43403393030166626 |
| keywords[8].display_name | Cancer cell |
| keywords[9].id | https://openalex.org/keywords/lead-compound |
| keywords[9].score | 0.42888760566711426 |
| keywords[9].display_name | Lead compound |
| keywords[10].id | https://openalex.org/keywords/biochemistry |
| keywords[10].score | 0.3126062750816345 |
| keywords[10].display_name | Biochemistry |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.2614113986492157 |
| keywords[11].display_name | Cancer |
| keywords[12].id | https://openalex.org/keywords/in-vitro |
| keywords[12].score | 0.2440468966960907 |
| keywords[12].display_name | In vitro |
| keywords[13].id | https://openalex.org/keywords/biology |
| keywords[13].score | 0.10966086387634277 |
| keywords[13].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1021/acs.jmedchem.3c00863 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S162030435 |
| locations[0].source.issn | 0022-2623, 1520-4804 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0022-2623 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Medicinal Chemistry |
| locations[0].source.host_organization | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_name | American Chemical Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320006 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Medicinal Chemistry |
| locations[0].landing_page_url | https://doi.org/10.1021/acs.jmedchem.3c00863 |
| locations[1].id | pmid:37594012 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of medicinal chemistry |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37594012 |
| locations[2].id | pmh:doi:10.7270/Q23B64G6 |
| locations[2].is_oa | False |
| locations[2].source | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Other/Protein-ligand binding data |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | |
| locations[3].id | doi:10.7270/q23b64g6 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S7407050887 |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | UC San Diego |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://doi.org/10.7270/q23b64g6 |
| indexed_in | crossref, datacite, pubmed |
| authorships[0].author.id | https://openalex.org/A5100431091 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ru Wang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[0].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[0].institutions[0].id | https://openalex.org/I200296433 |
| authorships[0].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ru Wang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[1].author.id | https://openalex.org/A5042450328 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0333-8739 |
| authorships[1].author.display_name | Tingting Du |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[1].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[1].institutions[0].id | https://openalex.org/I200296433 |
| authorships[1].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ting-Ting Du |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[2].author.id | https://openalex.org/A5100634313 |
| authorships[2].author.orcid | https://orcid.org/0009-0001-0618-4715 |
| authorships[2].author.display_name | Wenqiang Liu |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[2].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[2].institutions[0].id | https://openalex.org/I200296433 |
| authorships[2].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Wen-Qiang Liu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[3].author.id | https://openalex.org/A5100605129 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-1547-7640 |
| authorships[3].author.display_name | Yichen Liu |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[3].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[3].institutions[0].id | https://openalex.org/I200296433 |
| authorships[3].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yi-Chen Liu |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[4].author.id | https://openalex.org/A5103855130 |
| authorships[4].author.orcid | https://orcid.org/0009-0000-6419-3444 |
| authorships[4].author.display_name | Y. H. Yang |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[4].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[4].institutions[0].id | https://openalex.org/I200296433 |
| authorships[4].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ya-Dong Yang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[5].author.id | https://openalex.org/A5100614803 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2382-2034 |
| authorships[5].author.display_name | Jinping Hu |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[5].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[5].institutions[0].id | https://openalex.org/I200296433 |
| authorships[5].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jin-Ping Hu |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[6].author.id | https://openalex.org/A5101440562 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0731-6967 |
| authorships[6].author.display_name | Ming Ji |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[6].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[6].institutions[0].id | https://openalex.org/I200296433 |
| authorships[6].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Ming Ji |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[7].author.id | https://openalex.org/A5100442435 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2738-7896 |
| authorships[7].author.display_name | Beibei Yang |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[7].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[7].institutions[0].id | https://openalex.org/I200296433 |
| authorships[7].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Bei-Bei Yang |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050,China |
| authorships[8].author.id | https://openalex.org/A5100361279 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-9496-2280 |
| authorships[8].author.display_name | Li Li |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[8].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[8].institutions[0].id | https://openalex.org/I200296433 |
| authorships[8].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Li Li |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[9].author.id | https://openalex.org/A5100649680 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2035-4431 |
| authorships[9].author.display_name | Xiaoguang Chen |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[9].affiliations[0].raw_affiliation_string | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| authorships[9].institutions[0].id | https://openalex.org/I200296433 |
| authorships[9].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Xiao-Guang Chen |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.7270/q23b64g6 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2023-08-19T00:00:00 |
| display_name | Discovery, Optimization, and Evaluation of Novel N-(Benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine Analogues as Potent STAT3 Inhibitors for Cancer Treatment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11503 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cytokine Signaling Pathways and Interactions |
| related_works | https://openalex.org/W2891863700, https://openalex.org/W2383141715, https://openalex.org/W2367374011, https://openalex.org/W2358007372, https://openalex.org/W2004445097, https://openalex.org/W2362355507, https://openalex.org/W1993520606, https://openalex.org/W4390930506, https://openalex.org/W1995630420, https://openalex.org/W2886181943 |
| cited_by_count | 13 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.7270/q23b64g6 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S7407050887 |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | UC San Diego |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.7270/q23b64g6 |
| primary_location.id | doi:10.1021/acs.jmedchem.3c00863 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S162030435 |
| primary_location.source.issn | 0022-2623, 1520-4804 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0022-2623 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Medicinal Chemistry |
| primary_location.source.host_organization | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_name | American Chemical Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Medicinal Chemistry |
| primary_location.landing_page_url | https://doi.org/10.1021/acs.jmedchem.3c00863 |
| publication_date | 2023-08-18 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4242917665, https://openalex.org/W2561167444, https://openalex.org/W2331184627, https://openalex.org/W2421713479, https://openalex.org/W3119177747, https://openalex.org/W2021860656, https://openalex.org/W2027844562, https://openalex.org/W2085433278, https://openalex.org/W2893631054, https://openalex.org/W2127188999, https://openalex.org/W2029275361, https://openalex.org/W3003597218, https://openalex.org/W3095671931, https://openalex.org/W2786987313, https://openalex.org/W2016191221, https://openalex.org/W1548640328, https://openalex.org/W2103667952, https://openalex.org/W2078867215, https://openalex.org/W2530730624, https://openalex.org/W1812164980, https://openalex.org/W3011547660, https://openalex.org/W2606806850, https://openalex.org/W3185638550, https://openalex.org/W2593011550, https://openalex.org/W2117525838, https://openalex.org/W2470887676, https://openalex.org/W2807764751, https://openalex.org/W3185686704, https://openalex.org/W2333671104, https://openalex.org/W4224305404, https://openalex.org/W141627170, https://openalex.org/W1998420703, https://openalex.org/W1987474886, https://openalex.org/W2025787635, https://openalex.org/W2152995924, https://openalex.org/W2065080267, https://openalex.org/W4245515042, https://openalex.org/W2089214220, https://openalex.org/W3118432797, https://openalex.org/W2085007453 |
| referenced_works_count | 40 |
| abstract_inverted_index.3 | 6 |
| abstract_inverted_index.= | 97, 104 |
| abstract_inverted_index.a | 30, 36, 68, 132 |
| abstract_inverted_index.50 | 140 |
| abstract_inverted_index.In | 116 |
| abstract_inverted_index.an | 9 |
| abstract_inverted_index.as | 67 |
| abstract_inverted_index.at | 139 |
| abstract_inverted_index.in | 52, 124 |
| abstract_inverted_index.is | 8 |
| abstract_inverted_index.of | 4, 45, 59, 137 |
| abstract_inverted_index.on | 29 |
| abstract_inverted_index.to | 78 |
| abstract_inverted_index.SH2 | 76 |
| abstract_inverted_index.and | 2, 18, 42, 83, 100, 109, 114 |
| abstract_inverted_index.for | 12, 144 |
| abstract_inverted_index.the | 46, 75, 117 |
| abstract_inverted_index.was | 50, 65 |
| abstract_inverted_index.2.97 | 98 |
| abstract_inverted_index.3.26 | 105 |
| abstract_inverted_index.IL-6 | 54 |
| abstract_inverted_index.cell | 111 |
| abstract_inverted_index.gene | 85 |
| abstract_inverted_index.lead | 60 |
| abstract_inverted_index.rate | 136 |
| abstract_inverted_index.that | 72 |
| abstract_inverted_index.vivo | 125 |
| abstract_inverted_index.were | 40 |
| abstract_inverted_index.with | 23, 35, 131 |
| abstract_inverted_index.μM) | 99, 106 |
| abstract_inverted_index.65.3% | 138 |
| abstract_inverted_index.After | 57 |
| abstract_inverted_index.Based | 28 |
| abstract_inverted_index.DU145 | 94, 118 |
| abstract_inverted_index.STAT3 | 20, 70, 80 |
| abstract_inverted_index.binds | 74 |
| abstract_inverted_index.cells | 108 |
| abstract_inverted_index.cycle | 112 |
| abstract_inverted_index.novel | 37 |
| abstract_inverted_index.their | 43 |
| abstract_inverted_index.tumor | 133 |
| abstract_inverted_index.value | 96, 103 |
| abstract_inverted_index.Signal | 0 |
| abstract_inverted_index.arrest | 113 |
| abstract_inverted_index.cancer | 13, 107 |
| abstract_inverted_index.cells. | 56 |
| abstract_inverted_index.domain | 77 |
| abstract_inverted_index.growth | 134 |
| abstract_inverted_index.mg/kg, | 141 |
| abstract_inverted_index.model, | 120 |
| abstract_inverted_index.potent | 17 |
| abstract_inverted_index.showed | 123 |
| abstract_inverted_index.target | 11 |
| abstract_inverted_index.tested | 51 |
| abstract_inverted_index.(STAT3) | 7 |
| abstract_inverted_index.against | 92 |
| abstract_inverted_index.further | 145 |
| abstract_inverted_index.induced | 110 |
| abstract_inverted_index.inhibit | 79 |
| abstract_inverted_index.pathway | 49 |
| abstract_inverted_index.promise | 143 |
| abstract_inverted_index.remains | 26 |
| abstract_inverted_index.Compound | 87 |
| abstract_inverted_index.HEK-Blue | 53 |
| abstract_inverted_index.However, | 15 |
| abstract_inverted_index.compound | 61, 63, 121 |
| abstract_inverted_index.designed | 41 |
| abstract_inverted_index.directly | 73 |
| abstract_inverted_index.efficacy | 127 |
| abstract_inverted_index.reporter | 55 |
| abstract_inverted_index.scaffold | 31, 39 |
| abstract_inverted_index.therapy. | 14 |
| abstract_inverted_index.<b>40</b> | 64, 88, 122 |
| abstract_inverted_index.activator | 3 |
| abstract_inverted_index.antitumor | 126 |
| abstract_inverted_index.compounds | 34 |
| abstract_inverted_index.drug-like | 24 |
| abstract_inverted_index.exhibited | 89 |
| abstract_inverted_index.following | 128 |
| abstract_inverted_index.inhibitor | 71 |
| abstract_inverted_index.selective | 19, 69 |
| abstract_inverted_index.strategy, | 33 |
| abstract_inverted_index.xenograft | 119 |
| abstract_inverted_index.<b>12</b>, | 62 |
| abstract_inverted_index.MDA-MB-231 | 101 |
| abstract_inverted_index.activities | 91 |
| abstract_inverted_index.apoptosis. | 115 |
| abstract_inverted_index.attractive | 10 |
| abstract_inverted_index.downstream | 84 |
| abstract_inverted_index.identified | 66 |
| abstract_inverted_index.indicating | 142 |
| abstract_inverted_index.inhibition | 44, 135 |
| abstract_inverted_index.inhibitors | 22 |
| abstract_inverted_index.properties | 25 |
| abstract_inverted_index.transducer | 1 |
| abstract_inverted_index.combination | 32 |
| abstract_inverted_index.identifying | 16 |
| abstract_inverted_index.challenging. | 27 |
| abstract_inverted_index.development. | 146 |
| abstract_inverted_index.optimization | 58 |
| abstract_inverted_index.interleukin-6 | 47 |
| abstract_inverted_index.transcription | 5 |
| abstract_inverted_index.small-molecule | 21 |
| abstract_inverted_index.transcription. | 86 |
| abstract_inverted_index.translocation, | 82 |
| abstract_inverted_index.administration, | 130 |
| abstract_inverted_index.intraperitoneal | 129 |
| abstract_inverted_index.(IC<sub>50</sub> | 95, 102 |
| abstract_inverted_index.(IL-6)/JAK/STAT3 | 48 |
| abstract_inverted_index.phosphorylation, | 81 |
| abstract_inverted_index.antiproliferative | 90 |
| abstract_inverted_index.STAT3-overactivated | 93 |
| abstract_inverted_index.<i>N</i>-(benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine | 38 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5100649680 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I200296433 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.9354329 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |